FDA Drug Recalls

Recalls / Class II

Class IID-0193-2024

Product

PredniSONE Tablets, USP, 20 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801. NDC: 59746-175-06

Brand name
Prednisone
Generic name
Prednisone
Active ingredient
Prednisone
Route
Oral
NDCs
59746-172, 59746-782, 59746-173, 59746-175, 59746-783
FDA application
ANDA040362
Affected lot / code info
Batch 21P0659

Why it was recalled

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Recalling firm

Firm
CARDINAL HEALTHCARE
Manufacturer
Jubilant Cadista Pharmacuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7200 Cardinal Pl W, Dublin, Ohio 43017-1094

Distribution

Quantity
1 unit
Distribution pattern
Nationwide USA

Timeline

Recall initiated
2022-01-26
FDA classified
2023-12-26
Posted by FDA
2024-01-03
Terminated
2024-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0193-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Prednisone · FDA Drug Recalls